NASDAQ:ABUS   Arbutus Biopharma Corporation
$3.60 arrea was heavy resistance, now it's strong support.
Touching trend line and Over sold
RSI tuning green, prepping for another run up.

Yahoo Finance says it's 26% under valued.

Looks like a decent entry point with a SL below $3.60
Heavy Resistance at $4.50 and could turn into a H+S

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。